Corporate Governance
2022
Corporate Governance
Corporate Governance
- Group Structure and Shareholders
- Capital Structure
- Board of Directors
- Executive Committee
- Remuneration, Investments and Loans
- Shareholder Rights
- Change of Control and Defensive Measures
- Auditors
- Information Policy and Restricted Periods
This is an excerpt of Siegfried's Annual Report 2022.
All chapters can be found on our Investor Relations portal:
www.ir.siegfried.ch
02 | Siegfried Annual Report 2022 |
Corporate Governance
Group Structure and Shareholders
Good and transparent Corporate Governance allows Siegfried to develop and strengthen its long-term relationships with shareholders, customers and employees, thereby creating value for both the company and its stakeholders.
1. Group Structure and Shareholders
1.1 Group Structure
Dr. Andreas Casutt
Chairman of the Board
Dr. Wolfgang Wienand
Chief Executive Officer
Dr. Reto Suter | Arnoud Middel | ||||||
Chief Financial Officer | Chief Human Resources Officer | ||||||
Dr. Jürgen Roos | Marcel Imwinkelried | Marianne Späne | Irene Wosgien | ||||
Chief Scientific Officer | Chief Operating Officer | Chief Business Officer | Chief Operating Officer | ||||
Drug Products | Drug Substances |
03 | Siegfried Annual Report 2022 |
Corporate Governance
Group Structure and Shareholders
- Operational Group Structure (as of 31.12.2022)
- Legal Group Structure
Siegfried Holding AG, with registered office in Zofingen (Switzerland), is the parent company of the Siegfried Group. As of December 31, 2022, the Siegfried Group comprised 18 consolidated operating and holding companies worldwide. Siegfried Holding AG is listed on the SIX Swiss Exchange (valor symbol: SFZN, ISIN: CH0014284498). On December 31, 2022, the market capitalization of Siegfried Holding AG amounted to approximately CHF 2 584 million.
Siegfried Holding AG is the only listed company of the Siegfried Group. The Siegfried Group operates a total of eleven manufacturing sites through the following operational group companies:
Currency (LC) | Capital in LC | Holdings in % | ||||
Group Parent Company | ||||||
Siegfried Holding AG, Zofingen | CHF | 79 776 000 | ||||
Operational Companies | ||||||
1. Switzerland | ||||||
Siegfried AG, Zofingen | CHF | 20 000 000 | 100.00% | |||
Siegfried Evionnaz SA, Evionnaz | CHF | 1 000 000 | 100.00% | |||
2. Europe | ||||||
Siegfried Hameln GmbH, Hameln | EUR | 750 500 | 100.00% | |||
Siegfried PharmaChemikalien Minden GmbH, Minden | EUR | 50 000 | 100.00% | |||
Siegfried St. Vulbas SAS, St. Vulbas | EUR | 15 200 000 | 100.00% | |||
Siegfried Malta Ltd, Valletta | EUR | 100 000 | 100.00% | |||
Siegfried Barbera, S.L. | EUR | 503 000 | 100.00% | |||
Siegfried El Masnou, S.A. | EUR | 10 099 778 | 100.00% | |||
3. USA | ||||||
Siegfried USA, LLC, Pennsville | USD | 500 000 | 100.00% | |||
Alliance Medical Products, Inc., Irvine | USD | 116 521 | 100.00% | |||
4. Asia | ||||||
Siegfried (Nantong) Pharmaceuticals Co., Ltd., Nantong | CNY | 422 296 722 | 100.00% |
04 | Siegfried Annual Report 2022 |
Corporate Governance
Group Structure and Shareholders
1.2 Significant Shareholders
As of December 31, 2022, the shareholders listed in the following table originally reported holdings of 3% or more of the voting rights of Siegfried Holding AG. The detailed disclosure notifications pursuant to article 120 Swiss Financial Market Infrastructure Act (FMIA) can be found under https://www.six-exchange-regulation.com/en/home/publications/significant-shareholders.html?companyId=SIEGFRIED. The actual current shareholdings may deviate from the latest publicly disclosed holdings.
Reported holdings | ||||
Reported shares | in % | |||
Ernst Göhner Stiftung, Zug, Switzerland | 324 983 | 1 | 7.3 | |
Swisscanto Fondsleitung AG, Zürich, Switzerland | 132 977 | 2 | 3.0 | |
Credit Suisse Funds AG, Zürich, Switzerland | 129 258 | 3 | 3.0 | |
René Braginsky, Susanne Braginsky, David Braginsky; Zurich/Tel Aviv | 128 000 | 4 | 3.0 | |
Siegfried Holding AG (own shares) | 127 824 | 5 | 3.0 | |
Dimensional Holdings Inc., Wilmington, USA | 126 587 | 6 | 3.0 | |
Total | 969 629 | 22.3 | ||
1 According to the disclosure notification of May 17, 2022; including a purchase position of 98 983 shares, representing a shareholding of 2.23% (see also section 2.6).
-
According to the disclosure notification of May 3, 2022. ³ According to the disclosure notification of April 2, 2019.
4 According to the disclosure notification of December 12, 2018. 5 According to the disclosure notification of December 12, 2018. 6 According to the disclosure notification of March 3, 2018.
As of December 31, 2022, 7578 shareholders (excluding Siegfried Holding AG) were registered in the share register of Siegfried Holding AG, or known on the basis of the disclosure notifications pursuant to article 120 FMIA, representing a shareholding of 58.9% of the total share capital. The distribution of the shares among the shareholders was as follows:
D F | A: 1 577 | 1 - 10 shares | |
E | |||
C | A | B: 4 612 | 11 - 100 shares |
C: 1 192 | 101 - 1 000 shares | ||
D: 166 | 1 001 - 10 000 shares | ||
B | E: 22 | 10 001 - 100 000 shares | |
F: 9 | 100 001 - 1 000 000 shares* |
* incl. nominees without voting rights
05 | Siegfried Annual Report 2022 |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Siegfried Holding AG published this content on 22 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 February 2023 04:06:02 UTC.